Amgen Inc. Cedear (AMGN)
BCBA
Closed
Oct 7, 2026
Day's Range
22,090.0052 wk Range
12,320.00Overview - AMGN - Amgen Inc. Cedear
Key Statistics
Valuation
Enterprise Value
511,549.37T
P/E (Trailing)
‪0.18‬
PEG Ratio
‪0.0027‬
Price / Sales (TTM)
‪63.46‬
Price / Book
‪18.90‬
EV / EBITDA
‪19,448.45‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪22.95%‬
Operating Margin
‪35.54%‬
Return on Assets
‪8.66%‬
Return on Equity
‪91.47%‬
Ownership
Shares Outstanding
540.60M
Float
14.97B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.42‬
50-Day Avg
‪21,498.20‬
200-Day Avg
‪18,473.55‬
Dividends
Payout Ratio
‪0.41%‬
Frequency
Quarterly
Market Cap - AMGN - Amgen Inc. Cedear
Peers - AMGN - Amgen Inc. Cedear
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- AMGNBCBAAmgen Inc. Cedear2.41TMarket Cap+39.00%52-week change0.18P/E (Trailing)‪22.95%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,257.20TMarket Cap+29.46%52-week change57.14P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR353.29TMarket Cap+38.30%52-week change11.00P/E (Trailing)‪21.48%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR159.66TMarket Cap+22.83%52-week change16.85P/E (Trailing)‪14.52%‬Profit Margin
- AZNBCBAAstraZeneca PLC CEDEAR103.32TMarket Cap+22.93%52-week change6.68P/E (Trailing)‪17.02%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt75.56TMarket Cap+22.40%52-week change8.00P/E (Trailing)‪9.80%‬Profit Margin
- GILDBCBAGilead Sciences Inc.75.38TMarket Cap+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
Profile Summary - AMGN - Amgen Inc. Cedear
About
Amgen Inc. Cedear represents an interest in Amgen Inc., a global biotechnology company specializing in human therapeutics. The company discovers, develops, manufactures, and delivers innovative biological medicines designed to address serious and often chronic diseases across major therapeutic areas, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
